nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.23	1	CbGbCtD
Doxepin—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.022	0.0456	CcSEcCtD
Doxepin—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0216	0.105	CbGeAlD
Doxepin—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.0101	0.021	CcSEcCtD
Doxepin—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00978	0.0202	CcSEcCtD
Doxepin—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00945	0.0195	CcSEcCtD
Doxepin—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0086	0.0178	CcSEcCtD
Doxepin—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00812	0.0168	CcSEcCtD
Doxepin—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00797	0.0165	CcSEcCtD
Doxepin—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0158	CcSEcCtD
Doxepin—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0158	CcSEcCtD
Doxepin—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0158	CcSEcCtD
Doxepin—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0158	CcSEcCtD
Doxepin—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00709	0.0147	CcSEcCtD
Doxepin—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00699	0.0145	CcSEcCtD
Doxepin—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00678	0.014	CcSEcCtD
Doxepin—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00636	0.0132	CcSEcCtD
Doxepin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00628	0.013	CcSEcCtD
Doxepin—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0128	CcSEcCtD
Doxepin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00589	0.0122	CcSEcCtD
Doxepin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00582	0.012	CcSEcCtD
Doxepin—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00568	0.0118	CcSEcCtD
Doxepin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00568	0.0118	CcSEcCtD
Doxepin—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00564	0.0273	CbGeAlD
Doxepin—HTR2A—pons—amyotrophic lateral sclerosis	0.00557	0.027	CbGeAlD
Doxepin—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0108	CcSEcCtD
Doxepin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00499	0.0103	CcSEcCtD
Doxepin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00489	0.0101	CcSEcCtD
Doxepin—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00481	0.0233	CbGeAlD
Doxepin—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00475	0.023	CbGeAlD
Doxepin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00965	CcSEcCtD
Doxepin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00965	CcSEcCtD
Doxepin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00961	CcSEcCtD
Doxepin—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0045	0.00931	CcSEcCtD
Doxepin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00919	CcSEcCtD
Doxepin—DRD2—nerve—amyotrophic lateral sclerosis	0.00438	0.0212	CbGeAlD
Doxepin—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00436	0.0211	CbGeAlD
Doxepin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00896	CcSEcCtD
Doxepin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00863	CcSEcCtD
Doxepin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00856	CcSEcCtD
Doxepin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00411	0.0085	CcSEcCtD
Doxepin—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00409	0.0198	CbGeAlD
Doxepin—HTR2A—appendage—amyotrophic lateral sclerosis	0.00408	0.0197	CbGeAlD
Doxepin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00843	CcSEcCtD
Doxepin—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00821	CcSEcCtD
Doxepin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00812	CcSEcCtD
Doxepin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00786	CcSEcCtD
Doxepin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0078	CcSEcCtD
Doxepin—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00371	0.018	CbGeAlD
Doxepin—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00761	CcSEcCtD
Doxepin—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00363	0.0176	CbGeAlD
Doxepin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00746	CcSEcCtD
Doxepin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00746	CcSEcCtD
Doxepin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00718	CcSEcCtD
Doxepin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00709	CcSEcCtD
Doxepin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00698	CcSEcCtD
Doxepin—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00335	0.0162	CbGeAlD
Doxepin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00689	CcSEcCtD
Doxepin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00687	CcSEcCtD
Doxepin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00679	CcSEcCtD
Doxepin—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00328	0.0159	CbGeAlD
Doxepin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00669	CcSEcCtD
Doxepin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00665	CcSEcCtD
Doxepin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00665	CcSEcCtD
Doxepin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00652	CcSEcCtD
Doxepin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00648	CcSEcCtD
Doxepin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00648	CcSEcCtD
Doxepin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00647	CcSEcCtD
Doxepin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00638	CcSEcCtD
Doxepin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00629	CcSEcCtD
Doxepin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00624	CcSEcCtD
Doxepin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.003	0.00621	CcSEcCtD
Doxepin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00608	CcSEcCtD
Doxepin—HTR2A—nerve—amyotrophic lateral sclerosis	0.00289	0.014	CbGeAlD
Doxepin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00597	CcSEcCtD
Doxepin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00594	CcSEcCtD
Doxepin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00594	CcSEcCtD
Doxepin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00593	CcSEcCtD
Doxepin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0059	CcSEcCtD
Doxepin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00588	CcSEcCtD
Doxepin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00587	CcSEcCtD
Doxepin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00585	CcSEcCtD
Doxepin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00558	CcSEcCtD
Doxepin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00554	CcSEcCtD
Doxepin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00542	CcSEcCtD
Doxepin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00539	CcSEcCtD
Doxepin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00538	CcSEcCtD
Doxepin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00536	CcSEcCtD
Doxepin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00534	CcSEcCtD
Doxepin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00528	CcSEcCtD
Doxepin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00523	CcSEcCtD
Doxepin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0052	CcSEcCtD
Doxepin—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00251	0.0121	CbGeAlD
Doxepin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00512	CcSEcCtD
Doxepin—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00247	0.012	CbGeAlD
Doxepin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0051	CcSEcCtD
Doxepin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00509	CcSEcCtD
Doxepin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00505	CcSEcCtD
Doxepin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00503	CcSEcCtD
Doxepin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00242	0.005	CcSEcCtD
Doxepin—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00241	0.0117	CbGeAlD
Doxepin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00487	CcSEcCtD
Doxepin—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00234	0.0114	CbGeAlD
Doxepin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00482	CcSEcCtD
Doxepin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00481	CcSEcCtD
Doxepin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00478	CcSEcCtD
Doxepin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00469	CcSEcCtD
Doxepin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00467	CcSEcCtD
Doxepin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00466	CcSEcCtD
Doxepin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00465	CcSEcCtD
Doxepin—HTR6—nervous system—amyotrophic lateral sclerosis	0.00224	0.0109	CbGeAlD
Doxepin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00459	CcSEcCtD
Doxepin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00457	CcSEcCtD
Doxepin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00454	CcSEcCtD
Doxepin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0045	CcSEcCtD
Doxepin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00449	CcSEcCtD
Doxepin—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00216	0.0105	CbGeAlD
Doxepin—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00216	0.0105	CbGeAlD
Doxepin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00443	CcSEcCtD
Doxepin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00443	CcSEcCtD
Doxepin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00443	CcSEcCtD
Doxepin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00441	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0044	CcSEcCtD
Doxepin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00437	CcSEcCtD
Doxepin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00433	CcSEcCtD
Doxepin—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00208	0.0101	CbGeAlD
Doxepin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00428	CcSEcCtD
Doxepin—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00206	0.01	CbGeAlD
Doxepin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00424	CcSEcCtD
Doxepin—HRH2—nervous system—amyotrophic lateral sclerosis	0.00205	0.00993	CbGeAlD
Doxepin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00422	CcSEcCtD
Doxepin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00417	CcSEcCtD
Doxepin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00416	CcSEcCtD
Doxepin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00415	CcSEcCtD
Doxepin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.002	0.00414	CcSEcCtD
Doxepin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00412	CcSEcCtD
Doxepin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0041	CcSEcCtD
Doxepin—HRH2—central nervous system—amyotrophic lateral sclerosis	0.00197	0.00956	CbGeAlD
Doxepin—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00197	0.00955	CbGeAlD
Doxepin—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00196	0.00949	CbGeAlD
Doxepin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00404	CcSEcCtD
Doxepin—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00192	0.00929	CbGeAlD
Doxepin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00396	CcSEcCtD
Doxepin—CHRM4—brain—amyotrophic lateral sclerosis	0.00192	0.00928	CbGeAlD
Doxepin—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00189	0.00913	CbGeAlD
Doxepin—DRD2—brainstem—amyotrophic lateral sclerosis	0.00188	0.00911	CbGeAlD
Doxepin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00387	CcSEcCtD
Doxepin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00384	CcSEcCtD
Doxepin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00381	CcSEcCtD
Doxepin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00378	CcSEcCtD
Doxepin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00377	CcSEcCtD
Doxepin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00374	CcSEcCtD
Doxepin—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00179	0.00867	CbGeAlD
Doxepin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00369	CcSEcCtD
Doxepin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00366	CcSEcCtD
Doxepin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00366	CcSEcCtD
Doxepin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00363	CcSEcCtD
Doxepin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00363	CcSEcCtD
Doxepin—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00175	0.00848	CbGeAlD
Doxepin—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00172	0.00835	CbGeAlD
Doxepin—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00172	0.00834	CbGeAlD
Doxepin—HTR6—brain—amyotrophic lateral sclerosis	0.00171	0.0083	CbGeAlD
Doxepin—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00171	0.00829	CbGeAlD
Doxepin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0035	CcSEcCtD
Doxepin—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00169	0.00816	CbGeAlD
Doxepin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00347	CcSEcCtD
Doxepin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00337	CcSEcCtD
Doxepin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00335	CcSEcCtD
Doxepin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00335	CcSEcCtD
Doxepin—HRH2—brain—amyotrophic lateral sclerosis	0.00157	0.00759	CbGeAlD
Doxepin—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00154	0.00745	CbGeAlD
Doxepin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00313	CcSEcCtD
Doxepin—CHRM5—brain—amyotrophic lateral sclerosis	0.0015	0.00725	CbGeAlD
Doxepin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00304	CcSEcCtD
Doxepin—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00146	0.00706	CbGeAlD
Doxepin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00145	0.003	CcSEcCtD
Doxepin—ORM1—nervous system—amyotrophic lateral sclerosis	0.00144	0.00698	CbGeAlD
Doxepin—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00144	0.00697	CbGeAlD
Doxepin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0029	CcSEcCtD
Doxepin—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00672	CbGeAlD
Doxepin—ADRA1B—brain—amyotrophic lateral sclerosis	0.00137	0.00662	CbGeAlD
Doxepin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00281	CcSEcCtD
Doxepin—HTR2A—embryo—amyotrophic lateral sclerosis	0.00135	0.00656	CbGeAlD
Doxepin—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00134	0.00651	CbGeAlD
Doxepin—ADRA1D—brain—amyotrophic lateral sclerosis	0.00134	0.00648	CbGeAlD
Doxepin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0027	CcSEcCtD
Doxepin—HTR2C—nervous system—amyotrophic lateral sclerosis	0.0013	0.00628	CbGeAlD
Doxepin—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00129	0.00627	CbGeAlD
Doxepin—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00129	0.00627	CbGeAlD
Doxepin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00268	CcSEcCtD
Doxepin—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00129	0.00626	CbGeAlD
Doxepin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00267	CcSEcCtD
Doxepin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00266	CcSEcCtD
Doxepin—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00128	0.00618	CbGeAlD
Doxepin—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00604	CbGeAlD
Doxepin—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00124	0.00601	CbGeAlD
Doxepin—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00123	0.00595	CbGeAlD
Doxepin—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00122	0.00593	CbGeAlD
Doxepin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00252	CcSEcCtD
Doxepin—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00122	0.0059	CbGeAlD
Doxepin—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00118	0.00573	CbGeAlD
Doxepin—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00118	0.00571	CbGeAlD
Doxepin—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00117	0.00568	CbGeAlD
Doxepin—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00115	0.00558	CbGeAlD
Doxepin—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00114	0.00551	CbGeAlD
Doxepin—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00113	0.00547	CbGeAlD
Doxepin—CHRM3—nervous system—amyotrophic lateral sclerosis	0.0011	0.0053	CbGeAlD
Doxepin—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00109	0.00528	CbGeAlD
Doxepin—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00108	0.00524	CbGeAlD
Doxepin—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00511	CbGeAlD
Doxepin—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00509	CbGeAlD
Doxepin—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00104	0.00504	CbGeAlD
Doxepin—CHRM2—brain—amyotrophic lateral sclerosis	0.00103	0.00498	CbGeAlD
Doxepin—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00103	0.00497	CbGeAlD
Doxepin—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00102	0.00493	CbGeAlD
Doxepin—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00101	0.00487	CbGeAlD
Doxepin—HTR2C—brain—amyotrophic lateral sclerosis	0.00099	0.0048	CbGeAlD
Doxepin—DRD2—nervous system—amyotrophic lateral sclerosis	0.000985	0.00477	CbGeAlD
Doxepin—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000971	0.0047	CbGeAlD
Doxepin—Amitriptyline—SIGMAR1—amyotrophic lateral sclerosis	0.00097	0.591	CrCbGaD
Doxepin—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000968	0.00469	CbGeAlD
Doxepin—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000958	0.00464	CbGeAlD
Doxepin—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000949	0.0046	CbGeAlD
Doxepin—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000946	0.00458	CbGeAlD
Doxepin—SLC6A4—brain—amyotrophic lateral sclerosis	0.000939	0.00455	CbGeAlD
Doxepin—CHRM1—brain—amyotrophic lateral sclerosis	0.000935	0.00453	CbGeAlD
Doxepin—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000935	0.00453	CbGeAlD
Doxepin—HTR2B—brain—amyotrophic lateral sclerosis	0.00093	0.00451	CbGeAlD
Doxepin—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000927	0.00449	CbGeAlD
Doxepin—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000922	0.00447	CbGeAlD
Doxepin—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000914	0.00443	CbGeAlD
Doxepin—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000907	0.00439	CbGeAlD
Doxepin—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000902	0.00437	CbGeAlD
Doxepin—ABCB1—embryo—amyotrophic lateral sclerosis	0.000887	0.0043	CbGeAlD
Doxepin—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000865	0.00419	CbGeAlD
Doxepin—CHRM3—brain—amyotrophic lateral sclerosis	0.000837	0.00405	CbGeAlD
Doxepin—HTR1A—brain—amyotrophic lateral sclerosis	0.000834	0.00404	CbGeAlD
Doxepin—SLC6A2—brain—amyotrophic lateral sclerosis	0.000827	0.004	CbGeAlD
Doxepin—HRH1—nervous system—amyotrophic lateral sclerosis	0.000778	0.00377	CbGeAlD
Doxepin—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000771	0.00374	CbGeAlD
Doxepin—ADRA1A—brain—amyotrophic lateral sclerosis	0.000768	0.00372	CbGeAlD
Doxepin—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000764	0.0037	CbGeAlD
Doxepin—DRD2—brain—amyotrophic lateral sclerosis	0.000753	0.00365	CbGeAlD
Doxepin—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000749	0.00363	CbGeAlD
Doxepin—KCNH2—brain—amyotrophic lateral sclerosis	0.000742	0.00359	CbGeAlD
Doxepin—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000736	0.00356	CbGeAlD
Doxepin—ADRA2C—brain—amyotrophic lateral sclerosis	0.000732	0.00355	CbGeAlD
Doxepin—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000719	0.00348	CbGeAlD
Doxepin—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.00067	0.409	CrCbGaD
Doxepin—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00065	0.00315	CbGeAlD
Doxepin—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000626	0.00303	CbGeAlD
Doxepin—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000612	0.00296	CbGeAlD
Doxepin—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000602	0.00291	CbGeAlD
Doxepin—HRH1—brain—amyotrophic lateral sclerosis	0.000595	0.00288	CbGeAlD
Doxepin—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000592	0.00287	CbGeAlD
Doxepin—ADRA2A—brain—amyotrophic lateral sclerosis	0.000584	0.00283	CbGeAlD
Doxepin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000579	0.00281	CbGeAlD
Doxepin—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00057	0.00276	CbGeAlD
Doxepin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000567	0.00275	CbGeAlD
Doxepin—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000557	0.0027	CbGeAlD
Doxepin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000506	0.00245	CbGeAlD
Doxepin—HTR2A—brain—amyotrophic lateral sclerosis	0.000497	0.00241	CbGeAlD
Doxepin—CYP2D6—brain—amyotrophic lateral sclerosis	0.000453	0.00219	CbGeAlD
Doxepin—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000426	0.00206	CbGeAlD
Doxepin—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00041	0.00199	CbGeAlD
Doxepin—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000401	0.00194	CbGeAlD
Doxepin—ABCB1—brain—amyotrophic lateral sclerosis	0.000326	0.00158	CbGeAlD
Doxepin—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.18e-05	0.000277	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.17e-05	0.000276	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.15e-05	0.000272	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.15e-05	0.000272	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.14e-05	0.000272	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.14e-05	0.000271	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.13e-05	0.00027	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.12e-05	0.00027	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.12e-05	0.000269	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.11e-05	0.000268	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.11e-05	0.000267	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.11e-05	0.000267	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.08e-05	0.000264	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.08e-05	0.000263	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.07e-05	0.000263	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.07e-05	0.000262	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.06e-05	0.000262	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.06e-05	0.000262	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.06e-05	0.000261	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.05e-05	0.000261	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.04e-05	0.000259	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.04e-05	0.000259	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.03e-05	0.000258	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.03e-05	0.000258	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.03e-05	0.000257	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.01e-05	0.000255	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2e-05	0.000254	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	0.000251	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.98e-05	0.000251	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.95e-05	0.000247	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.95e-05	0.000247	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.94e-05	0.000246	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.94e-05	0.000246	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.94e-05	0.000246	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.94e-05	0.000246	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.93e-05	0.000245	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.93e-05	0.000244	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.92e-05	0.000244	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.91e-05	0.000243	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.91e-05	0.000242	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.9e-05	0.000241	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.89e-05	0.00024	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.88e-05	0.000239	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.88e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.86e-05	0.000236	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.85e-05	0.000235	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.85e-05	0.000235	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.85e-05	0.000234	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.84e-05	0.000234	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.84e-05	0.000233	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.84e-05	0.000233	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.83e-05	0.000232	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.82e-05	0.000231	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.82e-05	0.00023	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.81e-05	0.00023	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.81e-05	0.00023	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.79e-05	0.000227	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.78e-05	0.000226	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.78e-05	0.000226	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.77e-05	0.000225	CbGpPWpGaD
Doxepin—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.77e-05	0.000225	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.77e-05	0.000225	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.77e-05	0.000224	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.75e-05	0.000222	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.75e-05	0.000222	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.75e-05	0.000222	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.74e-05	0.000221	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.73e-05	0.00022	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.73e-05	0.000219	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.72e-05	0.000218	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.71e-05	0.000216	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.69e-05	0.000214	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.67e-05	0.000212	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.66e-05	0.00021	CbGpPWpGaD
Doxepin—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.65e-05	0.00021	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.64e-05	0.000209	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.64e-05	0.000209	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.63e-05	0.000207	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000206	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.61e-05	0.000205	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.59e-05	0.000202	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.59e-05	0.000201	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.59e-05	0.000201	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.58e-05	0.000201	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.58e-05	0.000201	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.58e-05	0.0002	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.57e-05	0.0002	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.56e-05	0.000198	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.55e-05	0.000197	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.53e-05	0.000194	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.52e-05	0.000193	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.52e-05	0.000192	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.5e-05	0.000191	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.5e-05	0.00019	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	0.000189	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	0.000189	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	0.000188	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	0.000188	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.48e-05	0.000187	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.47e-05	0.000187	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	0.000186	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	0.000185	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.46e-05	0.000185	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	1.46e-05	0.000185	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.45e-05	0.000184	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.45e-05	0.000184	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.44e-05	0.000183	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.43e-05	0.000182	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.42e-05	0.00018	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.41e-05	0.000179	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.4e-05	0.000178	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.38e-05	0.000174	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.000172	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.35e-05	0.000172	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.35e-05	0.000171	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.35e-05	0.000171	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.34e-05	0.00017	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.34e-05	0.00017	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000169	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.33e-05	0.000168	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.32e-05	0.000167	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.32e-05	0.000167	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.32e-05	0.000167	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.31e-05	0.000166	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.31e-05	0.000166	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.29e-05	0.000164	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.29e-05	0.000164	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.000159	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.25e-05	0.000158	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.23e-05	0.000156	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000155	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.22e-05	0.000155	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000155	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.22e-05	0.000155	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000154	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.22e-05	0.000154	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.21e-05	0.000153	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.2e-05	0.000153	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.2e-05	0.000152	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.17e-05	0.000149	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.17e-05	0.000148	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.15e-05	0.000146	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.15e-05	0.000146	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.15e-05	0.000146	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000146	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.14e-05	0.000145	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.14e-05	0.000144	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.13e-05	0.000144	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-05	0.000143	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000142	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.12e-05	0.000142	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000142	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.11e-05	0.000141	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.1e-05	0.00014	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.09e-05	0.000138	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.06e-05	0.000134	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.05e-05	0.000134	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	0.000133	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.04e-05	0.000132	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.04e-05	0.000132	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.04e-05	0.000131	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.03e-05	0.000131	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.02e-05	0.00013	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.01e-05	0.000129	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.01e-05	0.000128	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.01e-05	0.000128	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.01e-05	0.000128	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.97e-06	0.000127	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.96e-06	0.000126	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.93e-06	0.000126	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.8e-06	0.000124	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.77e-06	0.000124	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.75e-06	0.000124	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	9.46e-06	0.00012	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.46e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.36e-06	0.000119	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.36e-06	0.000119	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	9.24e-06	0.000117	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.23e-06	0.000117	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.15e-06	0.000116	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.04e-06	0.000115	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.99e-06	0.000114	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.96e-06	0.000114	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.85e-06	0.000112	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.8e-06	0.000112	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.75e-06	0.000111	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	8.7e-06	0.00011	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	8.63e-06	0.000109	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.61e-06	0.000109	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.54e-06	0.000108	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.5e-06	0.000108	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.26e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.13e-06	0.000103	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.95e-06	0.000101	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.94e-06	0.000101	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.83e-06	9.93e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.81e-06	9.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.79e-06	9.89e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.77e-06	9.86e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.74e-06	9.82e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.67e-06	9.73e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.67e-06	9.73e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.65e-06	9.7e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.63e-06	9.68e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.53e-06	9.55e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.5e-06	9.52e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.42e-06	9.42e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.39e-06	9.37e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.38e-06	9.36e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	7.37e-06	9.36e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.36e-06	9.34e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.34e-06	9.31e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.32e-06	9.28e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.3e-06	9.27e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.24e-06	9.19e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.23e-06	9.17e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.15e-06	9.07e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.1e-06	9.01e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.07e-06	8.97e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.92e-06	8.78e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.73e-06	8.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.71e-06	8.52e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.65e-06	8.44e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.63e-06	8.41e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.61e-06	8.39e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.59e-06	8.36e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.57e-06	8.34e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.51e-06	8.26e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.49e-06	8.23e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.48e-06	8.23e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.33e-06	8.03e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.03e-06	7.65e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6e-06	7.62e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.96e-06	7.57e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.91e-06	7.5e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.8e-06	7.35e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.77e-06	7.32e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.69e-06	7.22e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.61e-06	7.12e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.52e-06	7e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.09e-06	6.46e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.05e-06	6.41e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.01e-06	6.35e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5e-06	6.34e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.98e-06	6.32e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.96e-06	6.3e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.92e-06	6.24e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.9e-06	6.22e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.55e-06	5.78e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.9e-06	4.95e-05	CbGpPWpGaD
